bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.08.24.505078

Cyclic AMP competitively inhibits periplasmic phosphatases to coordinate nutritional growth with competence development of Haemophilus influenzae

Kronborg, K.·Zhang, Y.
View original source ↗Export metadata ↓

Abstract

Natural competence is an important means of horizontal gene transfer that bacteria use to gain new physiological traits such as multiple drug resistance. Most naturally competent bacteria tightly regulate the window of competence state to maximize their ecological fitness under specific conditions. Here we study the inhibitory effect of purine nucleotides on the natural competence in Haemophilus influenzae Rd KW20. We first identified a periplasmic acid phosphatase AphAEc of E. coli as a new cyclic AMP (cAMP)-binding protein. cAMP competitively inhibits AphAEc. Subsequently, we found that cAMP also competitively inhibits AphAHi and two additional periplasmic phosphatases NadNHi and HelHi of KW20. HelHi cleaves NADP to NAD, and NadNHi cleaves NAD to NMN and NR (nicotinamide ribose), providing the essential growth factor V for KW20. Consistently, we found that cAMP inhibits growth of KW20 in sBHI medium supplemented with NAD, but not NR. Moreover, the combined deletion of aphAHi, nadNHi, and helHi, but not the single or double deletion mutants, made KW20 immune to the inhibition of nucleotides on competence development. However, nucleosides still inhibited the competence of the triple mutant. Finally, cAMP in a dose-dependent manner restored the competence inhibited by the nucleotide GMP, but not by the nucleoside guanosine. Altogether, we revealed an antagonistic mechanism of cAMP and nucleotides in regulating cell growth and competence of H. influenzae. Similar mechanisms are discussed in other H. influenzae related organisms and Vibrio cholerae. Author summaryHaemophilus influenzae is an important human pathogen, causing respiratory tract infection including pneumonia. Extensive drug resistance is observed in Haemophilus influenzae species, which is attributed to their well-described natural competence system. Natural competence is a physiological state that some bacteria, under certain conditions, become active to take up external DNA and integrate it into the chromosome. External DNA may contain an antibiotic resistance gene and thereby confer antibiotic resistance on Haemophilus influenzae. Therefore, it is important to understand how natural competence of Haemophilus influenzae is regulated by external cues. Previously, it was found that the secondary messenger cyclic AMP (cAMP) activates while nucleotides inhibit the competence development of Haemophilus influenzae Rd KW20. However, the interplay between cAMP and nucleotides is unclear. Here we show that cAMP competitively inhibits three periplasmic phosphatases of Haemophilus influenzae Rd KW20 and thereby inhibits the utilization of nutritional nucleotides and the essential growth factor NAD. Via this mechanism, cAMP activates the competence development of Haemophilus influenzae Rd KW20 only after external nucleotides are sufficiently depleted, coupling growth arrest with competence development. Similar mechanisms are anticipated to function in bacteria closely related to Haemophilus influenzaee, and also Vibrio cholerae, another important human pathogen.

Source connections

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kronborg, K., Zhang, Y.. 2022-08-24. Cyclic AMP competitively inhibits periplasmic phosphatases to coordinate nutritional growth with competence development of Haemophilus influenzae. https://doi.org/10.1101/2022.08.24.505078

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗
bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗
bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗